Syndax Pharmaceuticals Inc Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Syndax Pharmaceuticals Inc Operating Income (Loss) for the quarter ending June 30, 2025 was -$69.4M, a 6.55% increase year-over-year.
  • Syndax Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending June 30, 2025 was -$339M, a 17.7% decline year-over-year.
  • Syndax Pharmaceuticals Inc annual Operating Income (Loss) for 2024 was -$340M, a 47.7% decline from 2023.
  • Syndax Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$230M, a 51.5% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$152M, a 679% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$340M -$110M -47.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 -$230M -$78.2M -51.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 -$152M -$178M -679% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 $26.2M +$97.6M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$71.4M -$13.9M -24.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$57.5M +$18.3M +24.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$75.9M -$13.9M -22.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 -$62M -$18.2M -41.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 -$43.8M -$23.3M -113% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 -$20.5M +$819K +3.84% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$21.3M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.